Enzymatic method for preparing rebaudioside N
US-11352653-B2 · Jun 7, 2022 · US
US11952604B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11952604-B2 |
| Application number | US-202217805626-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 6, 2022 |
| Priority date | Oct 21, 2016 |
| Publication date | Apr 9, 2024 |
| Grant date | Apr 9, 2024 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided is a method for preparing Rebaudioside J using an enzymatic method, comprising using rebaudioside A as a substrate, and making the substrate, in the presence of a glycosyl donor, react under the catalysis of a UDP-glycosyltransferase-containing recombinant cell and/or UDP-glycosyltransferase prepared therefrom to generate Rebaudioside J.
Opening claim text (preview).
The invention claimed is: 1. An enzymatic method for preparing Rebaudioside J, the method comprising reacting Rebaudioside A with a rhamnosyl donor in a reaction system comprising: recombinant cells comprising a UDP-glycosyltransferase, a UDP-glycosyltransferase prepared therefrom, or both the recombinant cells comprising the UDP-glycosyltransferase and the UDP-glycosyltransferase prepared therefrom, wherein the UDP-glycosyltransferase comprises an amino acid sequence having at least 80% sequence identity to SEQ ID NO: 2, wherein Rebaudioside A is converted to Rebaudioside J at a conversion rate greater than 90%. 2. The method of claim 1 , wherein the UDP-glycosyltransferase comprises an amino acid sequence having at least 90% sequence identity to SEQ ID NO: 2. 3. The method of claim 2 , wherein the rhamnosyl donor is a UDP-rhamnose. 4. The method of claim 2 , wherein the UDP-glycosyltransferase is a UGT-B from Oryza sativa. 5. The method of claim 2 , wherein the reaction system is aqueous and has a temperature of 35-45° C. and a pH of 7.5 to 8.5. 6. The method of claim 5 , wherein the reaction system comprises a phosphate buffer solution. 7. The method of claim 5 , wherein the reaction system further comprises a cell-permeabilizing agent. 8. The method of claim 7 , wherein the cell-permeabilizing agent is toluene and wherein the toluene has a concentration by volume of 1-3%. 9. The method of claim 2 , wherein the recombinant cell is a cell of a microorganism. 10. The method of claim 9 , wherein the microorganism is Escherichia coli, Saccharomyces cerevisiae , or Pichia pastoris. 11. The method of claim 2 , further comprising purifying the Rebaudioside J via resin isolation. 12. The method of claim 11 , wherein the Rebaudioside J purified via resin isolation has a purity greater than 95%.
having an oxygen atom of the saccharide radical directly bound to a condensed ring system having three or more carbocyclic rings, e.g. daunomycin, adriamycin · CPC title
Hexosyltransferases (2.4.1) · CPC title
Glucuronosyltransferase (2.4.1.17) · CPC title
Artificial sweetening agents · CPC title
produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.